#Inno4Vac
LightNews LightNews
europevaccine.bsky.social
EVI-led #Inno4Vac held its 5th Annual Meeting in Leiden. Over 75 representatives from 39 organisations came together to discuss the development of predictive biological & mathematical models of #vaccine performance and bio-manufacturing.🖥️ 🩺🦠

www.inno4vac.eu/post/inno4va...
@ihieurope.bsky.social
Inno4Vac Annual Meeting 2026 held in Leiden, The Netherlands
The Inno4Vac 5th Annual Meeting and its Subtopic satellite meetings were held from 29 September – 01 October 2026, involving more than 75 representatives from the project’s 39 Partner organisations. ...
www.inno4vac.eu
October 5, 2026 at 7:58 AM
smitslab.bsky.social
We are super grateful for our collaborators at @uniklinikkoeln.bsky.social @dzifbonn-koeln.bsky.social @goetheuni.bsky.social @helmholtzhzi.bsky.social, LUMC and the fruitful interactions with all partners in the #IHI2 @europevaccine.bsky.social #inno4vac project (www.inno4vac.eu).
10/10
Inno4Vac project
Inno4Vac, innovations to accelerate vaccine development and manufacture
www.inno4vac.eu
June 25, 2026 at 10:41 AM
olivercornely.bsky.social
#Inno4Vac advances #RSV, #influenza & Clostridioides difficile: standardising #clinical procedures, endpoints & data integrity in #CHIMs. Adaptive dose-escalation reduces timelines & enrollee numbers. High standards in ethics, conduct & reporting are key. www.sciencedirect.com/science/arti...
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report
Inno4Vac, a public-private partnership funded by the IMI2/EU/EFPIA Joint Undertaking (IMI2 JU), brings together academic institutions, SMEs, and pharm…
www.sciencedirect.com
January 17, 2025 at 11:23 AM
puneet021192.bsky.social
9/9 We also thank our generous funders:
@helmsleytrust.bsky.social , NIH, American Diabetes Association, @bt1dplay.bsky.social, EU Horizon 2020, iReceptorplus, Norwegian Cancer Society, Research Council of Norway, inno4vac, ERC Research, Marie Skłodowska-Curie Scientia fellows, nPOD.
December 14, 2024 at 11:12 AM
europevaccine.bsky.social
A new stakeholder workshop report from #Inno4Vac details regulatory discussions & recommendations for future use of #CHIMs in #vaccine research.

#EUfunded @ihieurope.bsky.social

www.inno4vac.eu/post/inno4va...
Inno4Vac publication outlines the future of ethical and regulatory oversight for human challenge studies in vaccine development
Published in Biologicals, the report summarises discussions and recommendations from the fourth Inno4Vac stakeholder workshop, "Refining the Regulatory and Ethics Context of Controlled Human Infection...
www.inno4vac.eu
July 3, 2026 at 8:06 AM
ihieurope.bsky.social
🧫 Say hello to the CADET-Hub, which can help to accelerate & streamline production processes for biopharma. Developed by Inno4Vac, the CADET-Hub could result in a 50% improvement in upstream yield & a 20% improvement in downstream productivity!
👉 lnkd.in/e2CDwQkt
#HorizonEU #VaccineManufacturing
Accelerating vaccine manufacturing using CADET-Hub written above an image of 2 researchers working in a lab
July 14, 2026 at 7:14 AM
europevaccine.bsky.social
🎉1,000+ views & counting!🎉

Curious about controlled human #Influenza virus infection models strain selection, immune assays, and their role in advancing #vaccine development?

📖Take a moment to read #Inno4vac workshop report➡️ doi.org/10.1111/irv....

#ViewsMilestone #CHIMs @ihieurope.bsky.social
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK
Controlled human infection models (CHIMs) are a critical tool for the understanding of infectious disease progression, characterising immune responses to infection and rapid assessment of vaccines or...
doi.org
January 22, 2026 at 11:32 AM
sciencebusiness.net
Supported by IMI, Inno4Vac has developed CADET-Hub to streamline #vaccine manufacturing. The open-source platform models the tightly controlled steps needed to turn a vaccine into a product that can be manufactured reliably at scale.
➡️More: www.ihi.europa.eu/news-events/...
@ihieurope.bsky.social
September 4, 2026 at 8:30 AM
europevaccine.bsky.social
“This will help to accelerate process development and optimisation while minimising experimental workload and costs, for research and industry alike".

Manufacturing #vaccines and biologicals is highly complex. The #Inno4Vac project developed open-access CADET-Hub to address this challenge ⬇️
ihieurope.bsky.social Innovative Health Initiative @ihieurope.bsky.social · Jul 14
🧫 Say hello to the CADET-Hub, which can help to accelerate & streamline production processes for biopharma. Developed by Inno4Vac, the CADET-Hub could result in a 50% improvement in upstream yield & a 20% improvement in downstream productivity!
👉 lnkd.in/e2CDwQkt
#HorizonEU #VaccineManufacturing
Accelerating vaccine manufacturing using CADET-Hub written above an image of 2 researchers working in a lab
July 16, 2026 at 12:06 PM
europevaccine.bsky.social
EVI was delighted to join the World Vaccine Congress Europe 2025. Dr. Irina Meln shared how EVI bridges academia, industry & regulators through projects like #Inno4Vac.🌍💉🎯
Read more➡️ www.euvaccine.eu/post/evi-at-...
EVI at World Vaccine Congress Europe 2025: Driving collaboration and innovation
The Partnerships & Access session during the World Vaccine Congress Europe 2025 focused on advancing vaccine development through collaboration, funding, and stakeholder engagement.
www.euvaccine.eu
November 14, 2025 at 8:27 AM